Back
15
Day Range
$101.10
$103.02
52-Week Range
$47.48
$107.90
Volume
50,204
50D / 200D Avg
$100.42
/
$81.20
Prev Close
$100.97
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (631 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 57.9 | 0.2 |
| P/B | 13.8 | 3.0 |
| ROE % | 24.8 | 3.6 |
| Net Margin % | 26.8 | 3.8 |
| Rev Growth 5Y % | 19.0 | 10.0 |
| D/E | 0.0 | 0.2 |
Analyst Price Target
Hold
$120.00
+17.9%
Forward P/E
48.93
Forward EPS
$2.08
EPS Growth (est.)
+0.0%
Est. Revenue
91.92M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2027 |
$2.32
$2.30 – $2.34
|
101.14M | 1 |
| FY2026 |
$2.08
$2.07 – $2.09
|
91.92M | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-10 | $0.48 | $0.54 | +12.5% |
| 2025-11-03 | $0.48 | $0.47 | -2.1% |
| 2025-08-01 | $0.45 | $0.49 | +8.9% |
| 2025-05-05 | $0.43 | $0.42 | -2.3% |
| 2025-02-13 | $0.45 | $0.44 | -2.2% |
| 2024-10-31 | $0.39 | $0.43 | +10.3% |
| 2024-08-01 | $0.37 | $0.42 | +13.5% |
| 2024-05-02 | $0.34 | $0.36 | +5.9% |
Dividend History
4 yr streakYield
0.01%
Payout Ratio
0.67%
Growth (3Y)
5.67%
Growth (5Y)
N/A
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Feb 23, 2026 | Mar 06, 2026 | $0.20 | 1.20% |
| Dec 17, 2025 | Dec 30, 2025 | $0.50 | 1.26% |
| Nov 14, 2025 | Nov 25, 2025 | $0.17 | 0.81% |
| Aug 18, 2025 | Aug 28, 2025 | $0.17 | 0.94% |
| May 20, 2025 | May 30, 2025 | $0.17 | 1.20% |
| Feb 24, 2025 | Mar 05, 2025 | $0.17 | 1.12% |
| Nov 15, 2024 | Nov 25, 2024 | $0.15 | 0.87% |
| Aug 20, 2024 | Aug 30, 2024 | $0.15 | 2.11% |
| May 17, 2024 | May 30, 2024 | $0.15 | 1.86% |
| Dec 21, 2023 | Jan 12, 2024 | $0.63 | 1.37% |
| Feb 10, 2023 | Feb 21, 2023 | $1.05 | 2.91% |
| Feb 16, 2022 | Feb 24, 2022 | $1.00 | 2.02% |
Key Takeaways
Revenue grew 18.99% annually over 5 years — strong growth
Earnings grew 16.88% over the past year
ROE of 24.78% indicates high profitability
Net margin of 26.82% shows strong profitability
Debt/Equity of 0.00 — conservative balance sheet
Generating 17.18M in free cash flow
Growth
Revenue Growth (5Y)
18.99%
Revenue (1Y)14.43%
Earnings (1Y)16.88%
FCF Growth (3Y)77.43%
Quality
Return on Equity
24.78%
ROIC20.73%
Net Margin26.82%
Op. Margin31.20%
Safety
Debt / Equity
0.00
Current Ratio7.98
Interest Coverage0.00
Valuation
P/E Ratio
57.87
Forward P/E48.93
P/B Ratio13.75
EV/EBITDA47.80
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 14.43% | Revenue Growth (3Y) | 13.07% |
| Earnings Growth (1Y) | 16.88% | Earnings Growth (3Y) | 14.35% |
| Revenue Growth (5Y) | 18.99% | Earnings Growth (5Y) | 24.60% |
| Profitability | |||
| Revenue (TTM) | 83.81M | Net Income (TTM) | 22.48M |
| ROE | 24.78% | ROA | 20.67% |
| Gross Margin | 76.75% | Operating Margin | 31.20% |
| Net Margin | 26.82% | Free Cash Flow (TTM) | 17.18M |
| ROIC | 20.73% | FCF Growth (3Y) | 77.43% |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 7.98 |
| Interest Coverage | 0.00 | ||
| Dividends | |||
| Dividend Yield | 0.01% | Payout Ratio | 0.67% |
| Dividend Growth (3Y) | 5.67% | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | 4 yrs | ||
| Valuation | |||
| P/E Ratio | 57.87 | Forward P/E | 48.93 |
| P/B Ratio | 13.75 | P/S Ratio | 15.52 |
| PEG Ratio | 3.35 | Forward PEG | N/A |
| EV/EBITDA | 47.80 | Fwd EV/EBITDA | 33.37 |
| Forward P/S | 14.15 | Fwd Earnings Yield | 2.04% |
| FCF Yield | 1.32% | ||
| Market Cap | 1.30B | Enterprise Value | 1.25B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 83.81M | 73.24M | 65.56M | 53.30M | 41.81M |
| Net Income | 22.48M | 19.23M | 17.19M | 12.83M | 9.33M |
| EPS (Diluted) | 1.75 | 1.50 | 1.35 | 1.02 | 0.74 |
| Gross Profit | 64.32M | 56.35M | 50.16M | 41.28M | 32.05M |
| Operating Income | 26.15M | 21.96M | 20.04M | 15.63M | 9.82M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 108.78M | 98.33M | 92.16M | 85.51M | 82.88M |
| Total Liabilities | 14.16M | 11.51M | 20.74M | 11.84M | 10.71M |
| Shareholders' Equity | 94.62M | 86.82M | 71.42M | 73.67M | 72.17M |
| Total Debt | 0.0 | 154,688.0 | 2.04M | 2.21M | 2.48M |
| Cash & Equivalents | 51.16M | 52.23M | 49.76M | 57.96M | 62.00M |
| Current Assets | 81.20M | 75.24M | 76.00M | 77.49M | 76.24M |
| Current Liabilities | 10.18M | 8.51M | 16.33M | 8.55M | 6.82M |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#152 of 158
Recent Activity
Entered
Growth Investing (Philip Fisher)
Mar 24, 2026